Transcription
Faculty Disclosure IndexDigestive Disease Week 2022May 21-24, 2022DDW Administration 4930 Del Ray Avenue Bethesda, MD 20814 301-272-0022 administration@ddw.org www.ddw.org
DDW Sponsoring Society CME Statements DisclosureRequirements for DDW 2022AASLD CME StatementThe American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council forContinuing Medical Education (ACCME) to provide continuing medical education for physicians. The AASLDdesignates this other activity (internet live meeting and internet enduring material) for AMA PRA Category 1Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in theactivity.It is the policy of AASLD to ensure balance, independence, objectivity and scientific rigor in all its educationalactivities. All faculty/authors participating in any AASLD provided activities, as well as planners and committeemembers, are expected to fully disclose all financial relationships with any commercial entity producinghealth-care related products and/or services during the past 24 months. AASLD will identify and mitigate allconflicts of interest prior to activity implementation. All disclosures are communicated to learners prior to theactivity starting.AGA Institute CME StatementThe AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) toprovide continuing medical education for physicians. The AASLD designates this other activity (internet livemeeting and internet enduring material) for AMA PRA Category 1 Credit(s) . Physicians should claim only thecredit commensurate with the extent of their participation in the activity.In accordance with ACCME’s Standards for Commercial Support of Continuing Medical Education, all facultyand planning partners must disclose any financial relationship(s) or other relationship(s) held within the past12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior todelivering the educational activity to learners.ASGE CME StatementThe American Society for Gastrointestinal Endoscopy (ASGE) is accredited by the Accreditation Council forContinuing Medical Education (ACCME) to provide continuing medical education for physicians. The AASLDdesignates this other activity (internet live meeting and internet enduring material) for AMA PRA Category 1Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in theactivity.DDW Administration 4930 Del Ray Avenue Bethesda, MD 20814 301-272-0022 administration@ddw.org www.ddw.org
ASGE requires all individuals who are in a position to control the content of an educational activity to discloseall relevant financial relationships with any Commercial Interest producing, marketing, re-selling, ordistributing health care goods or services consumed by, or used on, patients. Disclosures are made in writtenform prior to the start of the educational activity and any potential conflicts of interest that exist are resolvedprior to the start of the activity through the ASGE Conflict of Interest Resolution Policy process. All disclosuresare made available and communicated to the learner prior to the activity starting.SSAT CME StatementIn support of improving patient care, this activity has been planned and implemented by Cine-Med and theSociety for Surgery of the Alimentary Tract (SSAT). Cine-Med is jointly accredited by the Accreditation Councilfor Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and theAmerican Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Ciné-Med designates this live activity for AMA PRA Category 1Credit(s) . Physicians should claim only thecredit commensurate with the extent of their participation in the activity.Disclosure Legend1The speaker does not have any relevant financial or other relationship with manufacturer(s) orprovider(s) of commercial products or services that they will discuss during the presentation2The speaker does HAVE a relevant financial or other relationship with manufacturer(s) or provider(s) ofcommercial products or services that they will discuss during the presentation3No financial disclosure information providedDDW Administration 4930 Del Ray Avenue Bethesda, MD 20814 301-272-0022 administration@ddw.org www.ddw.org
DDW 2022 Financial Disclosure IndexLast lekAbdelmassehAbdel‐MisihAbdel‐RahmanAbdiAbdul QadeerAbdul RazzakAbduljaleelAbdulrahmanAbdurahimanAbeFirst NameA AzizA. nna sponseFinancial Disclosure32 Boston Scientific: Consulting; Steris Endoscopy: Consulting11111111111113112 Abbott: Speaking and Teaching1111111FUJIFILM: Grant/Research Support; Forrest One: Grant/Research Support;2 Olympus: Grant/Research Support11ADEPT‐GI: Patent Held/Filed; Allergan: Grant/Research Support; Censa:Consulting; Cin‐dome: Grant/Research Support; Med Study: Consulting;Medtronic: Consulting; Neurogastrix: Grant/Research Support; Takeda:Consulting; UpToDate: Independent Contractor; Vanda: Grant/Research2 Support1Apollo Endosurgery: Consulting; ConMed: Consulting; GI Dynamics:2 Grant/Research Support11Adicet, Alnylam, Astra Zeneca, Autem, Bayer, Beigene, Berry Genomics,Celgene, Cend, CytomX, Eisai, Eli Lilly, Exelixis, Flatiron, Genentech/Roche,Genoscience, Helio, Incyte, Ipsen, Legend Biotech, Merck, Nerviano, QED,Redhill, Rafael, Servier, Silenseed, Sobi, Surface Oncology, Therabionics,Vector, Yiviva: Consulting; Arcus, Agios, Astra Zeneca, BioNtech, BMS,Celgene, Flatiron, Genentech/Roche, Genoscience, Incyte, Polaris, Puma,2 QED, Silenseed, Yiviva: Grant/Research SupportAbbvie: Consulting; BMS: Consulting; Janssen: Consulting; Lilly: Consulting;Medtronics: Consulting; Pfizer: Consulting; Samsung Bioepis: Consulting;2 Takeda: Consulting; UCB: Consulting31112 Exact Sciences: Consulting; Pentax Medical: Grant/Research Support1AbbVie: Consulting; Alimentiv: Consulting; Arena: Consulting; Bellatrix:Consulting; Bristol Myers: Consulting; Eli Lilly: Consulting; Gilead:Consulting; Imedex: Consulting; Intellisphere: Consulting; JanssenPharmaceuticals: Consulting; Prime CME: Consulting; Prometheus Science:2 Consulting; Takeda: Consulting
DDW 2022 Financial Disclosure IndexLast NameAbu DayyehAbu �SbeihAbyAccarinoFirst hElizabethAnnaResponseFinancial DisclosureApollo Endosurgery: Grant/Research Support; BFKW: Consulting; BostonScientific: Consulting; EndoTagss: Consulting; Endogenex: AdvisoryCommittees or Review Panels; Hemostasis: Consulting; Johnson andJohnson: Speaking and Teaching; Medtronic: Consulting; Metamodix:Consulting; Nitinotes: Advisory Committees or Review Panels; Olympus:2 Speaking and Teaching; USGI Medical: Grant/Research denAdenijiKonradNiaAstraZeneca: Advisory Committees or Review Panels; Regeneron: AdvisoryCommittees or Review Panels; Sanofi‐Genzyme: Speaking and Teaching;UCSD (patent) Takeda (license): Patent Held/Filed; UpToDate: Speaking2 and Teaching; WebMD/MedScape: Speaking and Teaching111Amgen: Consulting; Gila Therapeutics: Stock Shareholder; Phenomix2 Sciences: Stock Shareholder112 Pfizer: Stock Shareholder11Janssen: Advisory Committees or Review Panels; Lilly: Speaking and2 Teaching; Takeda: Advisory Committees or Review fzalShashiArthurMaridiArthurElhamJoãoSheuliRao2 Takeda Pharmaceuticals International AG: Employment, Stock Shareholder1112 Nestle: Advisory Committees or Review ie: Advisory Committees or Review Panels, Grant/Research Support,Speaking and Teaching, Consulting; Arena Pharmaceuticals: Consulting;DiaSorin: Consulting; Eli Lilly: Advisory Committees or Review Panels,Consulting, Grant/Research Support; Gilead: Consulting; Janssen:Consulting, Advisory Committees or Review Panels, Grant/ResearchSupport, Speaking and Teaching; Pfizer: Consulting, Grant/ResearchSupport, Advisory Committees or Review Panels, Speaking and Teaching;TLL Pharmaceuticals: Advisory Committees or Review Panels, Consulting;Takeda: Advisory Committees or Review Panels, Consulting,2 Grant/Research Support, Speaking and Teaching111111112 Early Diagnostics Inc: garwalAghaie MeybodiAgnesAgnihotriAgopianAgostiniAgrawalAgrawal
DDW 2022 Financial Disclosure IndexLast adAhmadAhmadAhmadAhmedAhmedFirst emZahidAhmedAijazResponseFinancial hamedDong‐WonJi VineetGabrielCook Medical: Consulting; Interscope Inc: Consulting; Olympus USA:2 Consulting111111Astex Pharmaceuticals: Grant/Research Support; Cepheid: PatentHeld/Filed; Coca‐Cola: Stock Shareholder; IBM: Stock Shareholder; Nielsen2 IQGlaxoSmithKline Consumer Healthcare: Consulting; Laborie: AdvisoryCommittees or Review Panels; Medtronic: Consulting; Nestle:Grant/Research Support; Takeda: Advisory Committees or Review Panels;2 Vanda Pharmaceuticals: Grant/Research kobengAkshintalaAl AdraAl AhmariAl BalkhiAl ChoufeteAl KhalloufiAl MomaniAl lAhmet tarLaithSanaAbdullahAbdulrahmanQuazimAlmaza3D Matrix: Consulting; Boston Scientific: Consulting; ConMed: Consulting;2 Fujifilm Medical Systems: Consulting; Olympus America: Consulting113111111111112 Origin Endoscopy Inc: Board Membership111111111111111111111111131111
DDW 2022 Financial Disclosure IndexLast zyAlexanderFirst l‐HawaryAliAliAliAliAli bandAllamanAllebes nDanielaResponseFinancial Disclosure11112 fujifilm: Speaking and Teaching1111111lucid technologies: Consulting; meritage pharmacia: Stock Shareholder;2 regeneron: Grant/Research Support1111111Cook Endoscopy: Grant/Research Support; Creatics LLC: Grant/Research2 Support111311111111111189 Bio: Grant/Research Support; Akero: Grant/Research Support;Echosens: Speaking and Teaching; Fibronostics: Consulting; Gilead:Grant/Research Support; Hepagene: Grant/Research Support; Intercept:Grant/Research Support; Inventiva: Grant/Research Support; Madrigal:Grant/Research Support; NorthSea: Grant/Research Support; NovoNordisk: Grant/Research Support; Perspectum: Consulting; Pfizer:2 Grant/Research Support; Zydus: Grant/Research Support11112 Iterative Scopes, Inc: EmploymentArtugen: Consulting; BMS: Speaking and Teaching, Consulting; Baccain:Consulting; Finch Therapeutics: Consulting; Iterative scopes: AdvisoryCommittees or Review Panels; Janssen: Consulting; Merck: Grant/Research2 Support; Morphic: Consulting; Pfizer: Consulting; Servatus: Consulting1Gilead: Grant/Research Support; Novo Nordisk: Advisory Committees orReview Panels; Pfizer: Grant/Research Support; Target Pharma:2 Grant/Research Support12 Incyte: Advisory Committees or Review Panels
DDW 2022 Financial Disclosure IndexLast NameFirst eFinancial DisclosureAbbvie: Consulting; Amgen: Consulting; Biogen: Consulting; Boehringer‐Ingelheim: Consulting; Bristol Meyer Squibb: Consulting; Celgene:Consulting; Celltrion: Consulting; Ferring: Speaking and Teaching;Galapagos: Consulting; Genentech: Grant/Research Support; Gilead:Consulting; IQVIA: Consulting; Janssen: Consulting; Novartis: Consulting;Pfizer: Consulting; Roche: Consulting; Takeda: Speaking and Teaching;2 Tillots: Speaking and Teaching2 Endomed: Consulting11112 Ironwood Pharmaceuticals: aieAl‐SabahAlsabbagh AltayarAlvaradoAlvarez HerreroAlvarez‐GallegoChristopherJose mAbdulatifAhmadOsamaHaydeL.RafaelAbStats: Patent Held/Filed; Alnylam Pharmaceuticals: Consulting; ArenaPharmaceuticals: Consulting; Cellvizio: Consulting; Gilead Pharmaceuticals:Stock Shareholder; Madrigal Pharmaceuticals: Stock Shareholder; My Total2 Health: Stock Shareholder; Phathom Pharmaceuticals: ConsultingAlnylam: Consulting; Arena: Consulting; Gilead: Stock Shareholder;Madrigal: Stock Shareholder; My Total Health: Stock Shareholder;2 Phathom: AlvaroAl‐YamanAlzoubaidiDomenicoWaelDurayd2 InterceptPharma: Speaking and Teaching; Shionogi: Speaking and Teaching11
DDW 2022 Financial Disclosure IndexLast krishnanAnarwalaAnbazhaganAndalibFirst iAntonioliAntonoffAnukulkarnkusolJaneDaphneTiing onseFinancial Disclosure111221211111111311132111Carnot: Speaking and Teaching; Ferrer: Speaking and TeachingRegeneron: Employment, Stock ShareholderBayer Consumer Health: EmploymentAbbvie: Consulting; Pfizer: Speaking and Teaching2 boston scientific: Consulting; medtronic: Consulting; olympus: Consulting111311113Abbvie: Advisory Committees or Review Panels; Alimetry: StockShareholder; Bausch Health: Advisory Committees or Review Panels;Knight: Advisory Committees or Review Panels; Medtronic: Speaking andTeaching; Nimble Science: Stock Shareholder; Sandoz: Consulting; Takeda:Advisory Committees or Review Panels; Visceral Therapeutics: Patent2 Held/FiledSpeaker's fees, research support, Ad Boards, industry consultation withfunds received by my employer or a charity of my choice AbbVie, Allergan,Anatara, Atmo Capsule, Bayer, BMS 2020, Celgene, Celltrion, Falk, FerringFresenius Kabi, Gilead, Hospira, Immuninc, ImmunsanT, Janssen, MSD,2 Nestle, Novartis, Pfizer, Sandoz, Shire, Takeda, Vifor1111111111111FactorX: Speaking and Teaching; Pfizer: Grant/Research Support; Prime2 CME: Speaking and Teaching111
DDW 2022 Financial Disclosure IndexLast NameFirst NameResponseFinancial aArditoAreiaArevalo‐MoraArguelloArif oloJose hiJunichiAlexanderShabbaAbbott Nutrition: Advisory Committees or Review Panels; Allergan, Inc.:Advisory Committees or Review Panels; Altimmune, Inc.: AdvisoryCommittees or Review Panels; Bariatrix Nutrition: Advisory Committees orReview Panels; Cowen and Company, LLC: Advisory Committees or ReviewPanels; Curavit Clinical Research: Consulting; EnteroMedics Inc.: AdvisoryCommittees or Review Panels; Gelesis, Srl.: Advisory Committees orReview Panels; Janssen: Advisory Committees or Review Panels; JazzPharmaceuticals, Inc.: Advisory Committees or Review Panels; NovoNordisk, Inc.: Advisory Committees or Review Panels; Nutrisystem:Advisory Committees or Review Panels; Real Appeal: Advisory Committeesor Review Panels; Rhythm Pharmaceuticals: Advisory Committees orReview Panels; Roman Health Ventures, Inc.: Advisory Committees orReview Panels; Scientific Intake Ltd. Co.: Advisory Committees or ReviewPanels; SetPoint Health: Advisory Committees or Review Panels; TivityHealth, Inc.: Advisory Committees or Review Panels; Xeno Biosciences:Advisory Committees or Review Panels; Zafgen, Inc.: Advisory Committees2 or Review Panels131Boston Scientific: Consulting; Cook Endoscopy: Consulting; Medtronic Inc:2 Consulting111111112 Denali Therapeutics Inc: Employment1312 Boston Scientific: Speaking and Teaching1DavidAI VALI Inc: Advisory Committees or Review Panels, Patent Held/Filed;Cinclus Pharma: Advisory Committees or Review Panels; Fresenius Kabi:Speaking and Teaching; Nestlé Health Sciences: Grant/Research Support;Phathom Pharma: Consulting; Takeda: Speaking and Teaching, Advisory2 Committees or Review Panels; Viatris: Speaking and pinJuliaMarie‐ClaireAmandaSubhaEversonAbbvie: Consulting, Speaking and Teaching; Amgen: Speaking andTeaching; Arena: Consulting; Biogen: Speaking and Teaching; Bristol MyersSquibb: Consulting, Speaking and Teaching; Celltrion: Consulting, Speakingand Teaching; Eli Lilly: Consulting, Speaking and Teaching; Galapagos:Consulting, Speaking and Teaching; Gilead: Speaking and Teaching;Janssen: Consulting, Speaking and Teaching; MSD: Consulting, Speakingand Teaching; Pfizer: Consulting, Speaking and Teaching, Grant/ResearchSupport; Roche: Speaking and Teaching; Sandoz: Speaking and Teaching;2 Takeda: Consulting, Speaking and Artifon
DDW 2022 Financial Disclosure IndexLast NameFirst Joao PedroResponseFinancial DisclosureAmbu: Consulting; Fuji: Speaking and Teaching; Olympus: Speaking and2 Teaching1111111112 Intercept: Consulting31111111131311111112 Cellmax: Employment12 Rx.Health, spinout from Mount Sinai Health System: Board MembershipPPM Services: One of my current research projects is performed in2 collaboration with and financially supported by PPM Services.AbbVie: Advisory Committees or Review Panels, Speaking and Teaching;Amgen: Speaking and Teaching; Arena Pharmaceuticals: AdvisoryCommittees or Review Panels, Speaking and Teaching; Biogen:Grant/Research Support, Speaking and Teaching; Boehringer Ingelheim:Advisory Committees or Review Panels, Speaking and Teaching; Cellgene:Speaking and Teaching, Advisory Committees or Review Panels; CelltrionHealthcare: Advisory Committees or Review Panels; DrFalk Pharma:Consulting; Fresenius Kabi: Speaking and Teaching; Galapagos: AdvisoryCommittees or Review Panels, Speaking and Teaching; InDexPharmaceuticals: Consulting, Speaking and Teaching; Janssen‐Cilag:Advisory Committees or Review Panels, Speaking and Teaching; Lilly:Speaking and Teaching; MSD Sharp & Dohme: Speaking and Teaching;Samsung Bioepsis: Speaking and Teaching; Takeda Pharma: Consulting,2 Speaking and Teaching2 Gilead Sciences, Inc.: Speaking and Teaching11AstraZeneca: Advisory Committees or Review Panels; Dr Falk Pharma:Advisory Committees or Review Panels, Speaking and Teaching; EsoCapinc: Advisory Committees or Review Panels; Regeneron: Advisory2 Committees or Review Panels311
DDW 2022 Financial Disclosure IndexLast NameFirst NameAumaisAumkaewAuriemmaAustriaAutran ry nHimaja anSarahDivyaJuan ianJayraanYousefShyamDilhanaSenaDong HoonResponseFinancial DisclosureAbbvie: Advisory Committees or Review Panels, Speaking and Teaching;Amgen: Speaking and Teaching; Janssen: Grant/Research Support,Speaking and Teaching; Johnson& Johnson: Stock Shareholder; Lilly:Grant/Research Support; Lupin: Speaking and Teaching; Pfizer: Speakingand Teaching; Roche: Grant/Research Support; Takeda: Advisory2 Committees or Review Panels1111111IPSEN: Consulting; Takeda: Grant/Research Support; Zealand Pharma:2 Consulting1Applied Medical: Grant/Research Support; Bard/BD: Grant/ResearchSupport; Baxter: Grant/Research Support; Ethicon: Grant/ResearchSupport; Intuitive: Grant/Research Support; Medtronic: Grant/Research2 Support; Stryker: Grant/Research Support11Abbvie: Advisory Committees or Review Panels; BioFire Diagnostics:2 Consulting, Grant/Research Support; Janssen: Consulting12 Ethicon, Inc.: Consulting; Pinnacle Biologics, Inc.: Consulting1Cymabay: Grant/Research Support; Gilead: Speaking and Teaching,Grant/Research Support; Intercept: Grant/Research Support, Speaking and2 Teaching; Mirum: Grant/Research Support311111112 Clasado: Grant/Research Support; My Health Chart: Stock Shareholder11Danone: Grant/Research Support; Diananova: Grant/Research Support,2 Consulting; Roquette: Grant/Research Support, Consulting111113111111112 Aditum Bio: Consulting; Goodpath: Consulting1111
DDW 2022 Financial Disclosure IndexLast NameFirst NameBaertBagciBaharyBahirwaniBaiBaiano ilipUlasNathanRanjeetaJulioFedericaAyeshaGwang avanTatianaFrancescPaulronaldSreepriyaGayathri anerjeeSubhasBangBangBangBangruBankiBanksBansalJi YoungSeungminSung JoSushantFarzanehPeterAjayResponseFinancial DisclosureAbbVie: Advisory Committees or Review Panels, Grant/Research Support;Amgen: Grant/Research Support; Amgen: Advisory Committees or ReviewPanels; Arena: Advisory Committees or Review Panels, Speaking andTeaching; BMS: Advisory Committees or Review Panels; Celltrion: Speakingand Teaching; Falk: Speaking and Teaching; Ferring: Consulting; Janssen:Advisory Committees or Review Panels; MSD: Consulting; Pfizer: Speakingand Teaching; Sandoz: Advisory Committees or Review Panels; Takeda:Advisory Committees or Review Panels, Consulting; Vifor: Advisory2 Committees or Review Panels1131131312 Scioto Biosciences: Stock Shareholder111Bausch health: Grant/Research Support; Cosmo: Grant/Research Support;Mallinckrodt: Grant/Research Support; Norgine: Advisory Committees or2 Review Panels; Sequana: Grant/Research Support2 Enterasense Ltd.: Grant/Research Support111111111111Celgene: Consulting; Eli Lilly: Consulting; Janssen: Consulting; Pfizer:2 Consulting; Regeneron: Advisory Committees or Review Panels12 ADPT: Employment112 Takeda: Employment111111111Ambys Medicines, Inc: Consulting; Boston Scientific: Consulting,2 Grant/Research SupportBoston Scientific Corporation: Consulting; Olympus America Inc.:2 Consulting111113
DDW 2022 Financial Disclosure IndexLast NameFirst queBarawiBarba naSanketResponseFinancial DisclosureAmarin: Consulting; Madrigal: Advisory Committees or Review Panels;Pfizer: Consulting; The Kinetix Group: Consulting; Theratechnologies:2 Advisory Committees or Review Panels11111111Olympus: Consulting; abbvie: Speaking and Teaching; gilead: Speaking and2 Teaching; medtronic: Consulting1Alfasigma: Consulting; Biocodex: Consulting; Bromatech: Speaking andTeaching; Malesci: Board Membership; Parmalat: Consulting; Sanofi:2 Speaking and Teaching; Sofar: Consulting12 boston scientific: Consulting; pentax medical: Consulting1133111Cook: Advisory Committees or Review Panels; Imagia: Grant/ResearchSupport; Olympus: Advisory Committees or Review Panels; Pendopharm:2 Consulting, Advisory Committees or Review Panels11AbbVie, Inc: Consulting; Gilead: Consulting; Pfizer: Consulting; Takeda:2 Consulting; Target RWE: Consulting11Ambu: Consulting; Boston Scientific: Speaking and Teaching; ConMed:Speaking and Teaching; Cook Endoscopy: Consulting; Medtronic: Speaking2 and Teaching; Olympus America: Consulting; W.L. Gore: Consulting1112 Medtronic: Consulting; Norgine: Consulting31112 Boehringer Ingelheim: Grant/Research Support; Roche: Consulting131Bristol Myers Squibb: Advisory Committees or Review Panels; SERES2 Therapeutics: Advisory Committees or Review Panels111113111111
DDW 2022 Financial Disclosure IndexLast NameBasiliscoFirst NameGuidoResponseFinancial llBednarBeeBeedKevinLindaErinAhmadAhmad nyAndrewKendallPaulSandraLarenAlyseFilipYong MongAlexanderBefelerAlexEarli: Stock Shareholder; Merrck: Grant/Research Support; Novartis:Grant/Research Support; Repare: Grant/Research Support; Signet2 Therapeutics: Stock Shareholder1111111111112 Ziel Bio (aka iTi Health): Stock Shareholder1111111Abbvie: Advisory Committees or Review Panels; Nutriicia: Speaking and2 Teaching; Takeda: Advisory Committees or Review Panels111111131112 Regeneron: Employment, Stock Shareholder111113111Amgen: Stock Shareholder; Gilead: Stock Shareholder; Mallinckrodt:2 Grant/Research Support; dynavax: Stock arahAbbvie: Consulting; Anatara: Consulting; Bristol Meyers Squibb: Consulting;Celltrion: Consulting; Ferring: Consulting; Janssen: Consulting; Pfizer:2 Consulting; Progenity: Consulting; Suono: Consulting; Takeda: Consulting1111113BelleArthurBellinMelena2 BOSTON scientific: Speaking and Teaching; MAYOLI: Speaking and TeachingAriel Precision Medicine: Advisory Committees or Review Panels; Dexcom:Grant/Research Support; Insulet: Consulting; Viacyte: Grant/Research2 Support
DDW 2022 Financial Disclosure IndexLast orinBeniasBenitez rst NameMassimoNicolettaHiramWillem aCarlFrancescaFredrik uraSashaResponseFinancial Disclosure1111112 Hoffman‐La Roche: Consulting; McKesson Canada: Consulting11112 Apollo Endosurgery: Consulting; Fujifilm: Consulting1111Abott: Speaking and Teaching; Allergan: Advisory Committees or ReviewPanels; Coloplast: Advisory Committees or Review Panels; Danone:Advisory Committees or Review Panels; FrieslandCampina: Advis
Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of AASLD to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All faculty/authors participating in any AASLD provided activities, as well as planners and .
